Slavitt Doubts Congress Will Act Soon On Drug Pricing, Fears Rationing

Former CMS administrator Andy Slavitt tells Inside Heath Policy that he is skeptical Congress will pass drug-pricing legislation in short order -- though he maintains that such measures could move when Congress needs a payfor. While Slavitt did not name any specific legislation that would need a payfor, key industry stakeholders have told IHP they want Risk Evaluation and Mitigation Strategies reforms attached as a payoff to reauthorization of the Children's Health Insurance Program. Slavitt, in a...